Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

YILMAZ, SERKAN; Karakayali, Onur; Kale, Ebru; Akdogan, Ahmet

doi:10.1016/j.ajem.2017.08.053

Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

Copy For Citation

YILMAZ S., Karakayali O., Kale E., Akdogan A.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.36, no.3, pp.435-441, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 36 Issue: 3
Publication Date: 2018
Doi Number: 10.1016/j.ajem.2017.08.053
Journal Name: AMERICAN JOURNAL OF EMERGENCY MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.435-441
Kocaeli University Affiliated: Yes

Abstract

Aim: This study aims to evaluate the serum S100B levels to predict neuronal damage and poor clinical outcomes associated with the use of synthetic cannabinoids.